1. |
AIM1L |
ENSGALG00000031183 |
207 |
8 |
- |
1.000 |
1.000 |
1.000 |
1.000 |
1.000 |
1.000 |
1.000 |
- |
1.000 |
absent in melanoma 1-like, transcript variant X2 |
2. |
SULT1C |
SULT1C |
118 |
0.805 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.805 |
|
3. |
TMEM240 |
ENSGALG00000035387 |
14 |
0.788 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.788 |
transmembrane protein 240 [Source:HGNC Symbol;Acc:HGNC:25186] |
4. |
HAGH |
ENSGALG00000005398 |
168 |
0.775 |
- |
- |
- |
- |
- |
- |
0.775 |
- |
- |
- |
hydroxyacylglutathione hydrolase [Source:NCBI gene;Acc:416537] |
5. |
SPP1 |
ENSGALG00000010926 |
8 |
0.773 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.773 |
secreted phosphoprotein 1 [Source:NCBI gene;Acc:395210] |
6. |
TNFRSF11A |
ENSGALG00000045642 |
388 |
0.764 |
- |
- |
- |
- |
- |
- |
- |
0.764 |
- |
- |
TNF receptor superfamily member 11a [Source:HGNC Symbol;Acc:HGNC:11908] |
7. |
SPG20 |
|
22 |
0.762 |
- |
- |
- |
- |
- |
0.762 |
- |
- |
- |
- |
spastic paraplegia 20 (Troyer syndrome), transcript variant X1 |
8. |
CDK19 |
ENSGALG00000015051 |
26 |
0.752 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.752 |
cyclin dependent kinase 19 [Source:HGNC Symbol;Acc:HGNC:19338] |
9. |
RBM41 |
ENSGALG00000004832 |
838 |
0.744 |
- |
- |
- |
- |
- |
- |
0.744 |
- |
- |
- |
RNA binding motif protein 41 [Source:HGNC Symbol;Acc:HGNC:25617] |
10. |
CYP1A1 |
ENSGALG00000001325 |
6 |
0.743 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.743 |
cytochrome P450, family 1, subfamily A, polypeptide 1 [Source:NCBI gene;Acc:396052] |
11. |
NSMAF |
ENSGALG00000038838 |
2221 |
0.739 |
- |
- |
- |
- |
- |
- |
- |
0.739 |
- |
- |
neutral sphingomyelinase activation associated factor [Source:HGNC Symbol;Acc:HGNC:8017] |
12. |
DICER1 |
ENSGALG00000010999 |
1222 |
0.738 |
- |
- |
- |
- |
- |
0.738 |
- |
- |
- |
- |
dicer 1, ribonuclease III [Source:NCBI gene;Acc:423437] |
13. |
USH1C |
ENSGALG00000006192 |
63 |
0.734 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.734 |
USH1 protein network component harmonin [Source:HGNC Symbol;Acc:HGNC:12597] |
14. |
ENSGALG00000021024 |
ENSGALG00000021024 |
1339 |
0.729 |
- |
- |
- |
- |
- |
0.729 |
- |
- |
- |
- |
|
15. |
C13H5ORF41 |
C13H5ORF41 |
1051 |
0.727 |
- |
- |
- |
- |
- |
- |
- |
0.727 |
- |
- |
|
16. |
AK2 |
ENSGALG00000003597 |
1415 |
0.718 |
- |
- |
- |
- |
- |
- |
- |
0.718 |
- |
- |
adenylate kinase 2 [Source:HGNC Symbol;Acc:HGNC:362] |
17. |
AGPAT5 |
ENSGALG00000016329 |
1399 |
0.715 |
- |
- |
- |
- |
- |
- |
- |
0.715 |
- |
- |
1-acylglycerol-3-phosphate O-acyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:20886] |
18. |
KLF8 |
ENSGALG00000007570 |
1651 |
0.715 |
- |
- |
- |
- |
- |
- |
- |
0.715 |
- |
- |
Kruppel-like factor 8, transcript variant X6 |
19. |
SLC2A9 |
ENSGALG00000014971 |
751 |
0.711 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.711 |
solute carrier family 2 member 9 [Source:HGNC Symbol;Acc:HGNC:13446] |
20. |
KCTD14 |
ENSGALG00000017266 |
31 |
0.71 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.710 |
potassium channel tetramerization domain containing 14 [Source:NCBI gene;Acc:419029] |
21. |
SMAD7A |
SMAD7A |
78 |
0.709 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.709 |
|
22. |
PON2 |
ENSGALG00000009689 |
1416 |
0.707 |
- |
- |
- |
- |
- |
- |
- |
0.707 |
- |
- |
paraoxonase 2 [Source:NCBI gene;Acc:395830] |
23. |
FCRL2 |
FCRL2 |
488 |
0.704 |
- |
- |
- |
- |
- |
- |
- |
0.704 |
- |
- |
|
24. |
SH2D4A |
ENSGALG00000010122 |
206 |
0.704 |
- |
- |
- |
- |
- |
- |
- |
0.704 |
- |
- |
SH2 domain containing 4A [Source:HGNC Symbol;Acc:HGNC:26102] |
25. |
CRYBA1 |
ENSGALG00000004035 |
176 |
0.704 |
- |
- |
- |
- |
- |
- |
- |
0.704 |
- |
- |
crystallin beta A1 [Source:NCBI gene;Acc:396499] |